脂蛋白作为药理目标:前提,承诺和前景
在PubMed上查看摘要
概括
此摘要是机器生成的。脂蛋白 (a) [Lp(a) ]是动脉样硬化心血管疾病的强有力的遗传风险因素. 识别高Lp(a) 水平的个体可以指导预防策略并减少心血管事件.
科学领域
- 心脏病学
- 遗传学
- 生物化学
背景情况
- 动脉样性心血管疾病 (ASCVD) 构成了全球重大健康挑战.
- 脂蛋白 (a) [Lp(a) ]被认为是一个独立的ASCVD风险因素,超过LDL胆固醇.
- 通过包括氧化脂积累和干扰纤维解的促炎和促血栓机制,促进ASCVD.
研究的目的
- 强调Lp (a) 作为心血管风险因素的重要性.
- 讨论Lp (a) 驱动性动脉血栓形成的机制.
- 审查目前和新兴的治疗策略,以减少Lp.
主要方法
- 对遗传研究 (孟德尔随机化) 和临床试验分析的审查.
- 对Lp (a) 动脉动脉道的检查 (例如,血管壁进入,受体相互作用).
- 目前正在进行的新型Lp降低疗法的临床研究概述.
主要成果
- 基因研究证实Lp (a) 升高与心血管结果之间存在因果关系.
- 在等分的基础上,Lp (a) 显著高于LDL.
- 针对Lp (a) 的多种药物类别正在临床开发中,显示出治疗前景.
结论
- 一次性Lp (a) 测量可以识别因其遗传基础而处于危险状态的个体.
- 预计Lp (a) 的治疗降低会减轻心血管风险.
- 增加Lp (a) 检测和向治疗为预防心血管事件提供了有希望的全民战略.
相关概念视频
Hyperlipidemia, a medical condition often referred to as high cholesterol, is characterized by abnormally elevated levels of lipids in the bloodstream. When present in excess, these lipids, specifically cholesterol and triglycerides, can lead to serious health complications, often involving cardiovascular diseases. Illnesses like atherosclerosis, heart attacks, and pancreatitis have all been linked to untreated hyperlipidemia. This means controlling and regulating cholesterol and triglyceride...
Drug transporters are critical in drug absorption, distribution, and excretion processes. They should be included in physiological-based pharmacokinetic (PBPK) models, which help predict human drug disposition. However, predicting this is challenging during drug development, especially when liver transport is involved. However, with a realistic representation of body transport processes, an accurate model may be possible.
A recent model describes pravastatin's hepatobiliary excretion,...
Prostacyclin receptor agonists are a class of therapeutic agents integral to managing pulmonary arterial hypertension (PAH). These drugs operate by mimicking the action of prostaglandin I2, or PGI2, a naturally occurring compound in the body.
These agonists bind to the IPR receptor situated on the plasma membrane of the pulmonary artery smooth muscle cells. This binding triggers a cascade of reactions known as the GS-AC-cAMP-PKA pathway. This pathway results in the relaxation of smooth muscle...
Drug binding to proteins is a complex phenomenon influenced by various drug-related factors, each playing a significant role in the interaction between drugs and proteins within the body.
One crucial factor in drug-protein binding is the drug's lipophilicity or its affinity for fat. More lipophilic drugs tend to have higher binding extents. For example, highly lipophilic drugs like cloxacillin exhibit substantial protein binding, with as much as 95% of the drug binding to proteins. In...
Understanding serum lipids is crucial for maintaining cardiovascular health and preventing heart disease and stroke.
Serum lipids are fats and fatty substances in the blood and are crucial for various bodily functions, including energy storage, cellular structure, and hormone production. Serum lipids consist of cholesterol, triglycerides, and phospholipids.
Cholesterol is a soft, fat-like substance found in all body cells. It is crucial for producing hormones, vitamin D, and substances that aid...
Drug binding to proteins is a key aspect of pharmacokinetics and can influence a drug's distribution, absorption, and elimination in the body. Several factors, including the drug's physiochemical properties, protein concentration, disease states, and the number of binding sites on the protein, influence this process.
The physicochemical properties of a drug play a significant role in its ability to bind to proteins. Lipophilic drugs, which dissolve in fats, oils, and lipids, can be...